Christoffer T. Nielsen

Copenhagen, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 63 publications

A novel immunoassay for neostatin-7 quantifies basement membrane remodeling and reveals an association with reduced pulmonary function in systemic sclerosis.

A novel immunoassay for neostatin-7 quantifies basement membrane remodeling and reveals an association with reduced pulmonary function in systemic sclerosis.

Journal: Scientific reports

Published: March 26, 2026

Fibroblast activation protein inhibitor PET for monitoring fibrotic diseases

Fibroblast activation protein inhibitor PET for monitoring fibrotic diseases

Journal: Ugeskrift for laeger

Published: November 20, 2025

Arthritis in Cystic Fibrosis-Comparison of a Single-Center Cohort and Published Case Reports/Series and a Review of the Literature.

Arthritis in Cystic Fibrosis-Comparison of a Single-Center Cohort and Published Case Reports/Series and a Review of the Literature.

Journal: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica

Published: May 12, 2025

Radio-labelled fibroblast activation protein inhibitors in interstitial lung diseases - a systematic review.

Radio-labelled fibroblast activation protein inhibitors in interstitial lung diseases - a systematic review.

Journal: Autoimmunity reviews

Published: March 11, 2025

Title Not Found

Title Not Found

Journal: Ugeskrift for laeger

Published: November 22, 2024

Fibroblast activities are associated with prolonged QTc and pulmonary arterial hypertension in patients with systemic sclerosis.

Fibroblast activities are associated with prolonged QTc and pulmonary arterial hypertension in patients with systemic sclerosis.

Journal: Clinical and experimental rheumatology

Published: August 08, 2024

Treatment experiences with focus on IL-6R inhibition in patients with VEXAS syndrome and a case of remission with azacytidine treatment.

Treatment experiences with focus on IL-6R inhibition in patients with VEXAS syndrome and a case of remission with azacytidine treatment.

Journal: Rheumatology (Oxford, England)

Published: October 12, 2023

Elevated Antibody Titers to Epstein-Barr Virus and Cytomegalovirus in Patients with Drug-Induced Lupus.

Elevated Antibody Titers to Epstein-Barr Virus and Cytomegalovirus in Patients with Drug-Induced Lupus.

Journal: Viruses

Published: March 22, 2023

Pirfenidone in rheumatoid arthritis-associated interstitial lung disease.

Pirfenidone in rheumatoid arthritis-associated interstitial lung disease.

Journal: The Lancet. Respiratory medicine

Published: January 06, 2023

Myositis-related autoantibody profile and clinical characteristics stratified by anti-cytosolic 5'-nucleotidase 1A status in connective tissue diseases.

Myositis-related autoantibody profile and clinical characteristics stratified by anti-cytosolic 5'-nucleotidase 1A status in connective tissue diseases.

Journal: Muscle & nerve

Published: November 14, 2022

A cluster of type II interferon-regulated genes associates with disease activity in patients with systemic lupus erythematosus.

A cluster of type II interferon-regulated genes associates with disease activity in patients with systemic lupus erythematosus.

Journal: Journal of autoimmunity

Published: May 25, 2022

Gender- and age-specific rates of heart failure and other adverse cardiovascular outcomes in systemic sclerosis.

Gender- and age-specific rates of heart failure and other adverse cardiovascular outcomes in systemic sclerosis.

Journal: Rheumatology (Oxford, England)

Published: November 17, 2021

Showing 1-12 of 63

Last Updated: 09/26/2026